Evaluating the potential of multi-cancer detection (MCD) tests in Australia

MCD Spotlight is a collaborative research program evaluating the potential of MCD tests to reduce cancer burden and improve health outcomes in Australia.

Early detection improves outcomes for almost all cancers. However, for most cancers, there is currently no screening program in Australia.

Multi-cancer detection (MCD) tests have the potential to change this. In the future, MCD tests might be able to identify people with a wide range of cancers who do not have symptoms yet, by using a single non-invasive test that snapshots many different cancer biomarkers.

The MCD Spotlight study is leading new research into whether and how MCD tests could improve cancer outcomes in Australia

Our Key Goals

Consolidate international
evidence on MCD tests

Learn More

Map how MCD tests could fit
into Australia’s healthcare

Learn More

Evaluate potential MCD test
benefits, harms, and costs

Learn More

Create a roadmap for
future policy and practice

Learn More

Interested in staying up to date?

Subscribe to receive key updates and highlights on the MCD Spotlight research program delivered to your inbox up to 4 times per year

To top